STRS Ohio’s Lifecore Biomedical LFCR Stock Holding History

STRS Ohio’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$50.7K	Buy	+7,700	New	+$35.7K	﹤0.01%	2038

Other funds holding LFCR

CWC Advisors Lake Oswego, Oregon $215M AUM 18.92% 1-Year Est. Return

MAA

Mraz Amerine & Associates Modesto, California $640M AUM 12.53% 1-Year Est. Return

Covestor London, United Kingdom $157M AUM 35.87% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Ulland Investment Advisors Minneapolis, Minnesota $142M AUM 22.97% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

STRS Ohio's LFCR Position: Q3 2026 in Review

STRS Ohio opened a new position in Lifecore Biomedical (LFCR) in Q3 2026: 7,700 shares worth $50.7K. The stake represents ﹤0.01% of the portfolio and ranks #2038 among its holdings.

18 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

STRS Ohio held 7,700 shares of Lifecore Biomedical worth $50.7K as of Q3 2026.
Lifecore Biomedical was a new STRS Ohio position in Q3 2026.
Lifecore Biomedical made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #2038 holding.
18 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.